Free/Total PSA (F/T ratio) kinetics in patients with clinically localized prostate cancer undergoing radical prostatectomy

被引:13
|
作者
Gregorakis, AK
Malovrouvas, D
Stefanakis, S
Petraki, K
Scorilas, A [1 ]
机构
[1] Univ Athens, Fac Biol, Dept Biochem & Mol Biol, Athens 15701, Greece
[2] Univ Athens, Attikon Gen Hosp, Dept Urol, Athens, Greece
[3] Evangelismos Gen Hosp, Dept Urol, Athens, Greece
[4] Evangelismos Gen Hosp, Dept Pathol, Athens, Greece
关键词
tumor biomarkers; kallikreins; prostate; prostate cancer; PSA; free PSA; prostate specific antigen; serine proteases;
D O I
10.1016/j.cccn.2005.03.027
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: In this paper we study the Free/Total PSA kinetics in patients with clinically localized prostate cancer undergoing radical prostatectomy. Methods: Serum PSA, Free PSA and Free/Total Ratio were determined preoperatively, at the time of prostate removal (0 time) and then at 3, 6, 12, 24, 48, 72 and 168 h, from 9 patients with clinically localized prostate cancer who underwent radical retropubic prostatectomy. The elimination rates and half-lives of Total, Free PSA and F/T Ratio were studied applying one and two compartment models for pharmacokinetic analysis. Results: Surgical manipulations of the prostate caused a mean 2.16-fold increase. of PSA, 12-fold increase of free PSA and 4.2-fold increase of F/T PSA ratio. Removal of the prostate caused a rapid biphasic, biexponential elimination of Free PSA with a mean half-life of 0.8 h for the alpha (a) phase and 32.6 h for the beta (b) phase. PSA was eliminated following a rapid exponential (a) phase with a half-life of 1.15 h and a non-exponential (b) phase with a half-life of 71.96 h. Free/Total PSA followed a biphasic kinetic, with an initial exponential elimination phase and a mean half-life of 2.6 h and a second non-exponential increase phase with a doubling time of 130.8 h. Free/Total PSA reached its nadir very soon, at the first postoperative 24 h. Conclusions: Free/Total PSA kinetic after radical prostatectomy reflects the differences of Free and Total PSA elimination kinetics. Free/Total Ratio follows a biphasic kinetic, with an initial rapid exponential elimination phase, which is affected mainly by the rapid exponential (a) phase of Free PSA elimination and a second slow increase, which is affected mainly by the terminal non-exponential (b) phase of PSA elimination. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:196 / 201
页数:6
相关论文
共 50 条
  • [1] Total and free PSA kinetics in patients without prostate cancer undergoing radical cystoprostatectomy
    Gregorakis, Alkibiades K.
    Stefanakis, Stefanos
    Malovrouvas, Dimitrios
    Petraki, Konstantina
    Gourgiotis, Dirnitrios
    Scorilas, Andreas
    PROSTATE, 2008, 68 (07): : 759 - 765
  • [2] Shift of tumor features in patients with clinically localized prostate cancer undergoing radical prostatectomy since the beginning of the PSA era
    Augustin, Herbert
    Auprich, Marco
    Stummvoll, Philipp
    Lipsky, Katja
    Pummer, Karl
    Petritsch, Peter
    WIENER KLINISCHE WOCHENSCHRIFT, 2006, 118 (11-12) : 348 - 354
  • [3] The preoperative serum ratio of total prostate specific antigen (PSA) to free testosterone (FT), PSA/FT index ratio, and prostate cancer. Results in 220 patients undergoing radical prostatectomy
    Porcaro, Antonio B.
    Caruso, Beatrice
    Terrin, Alessandro
    De Luyk, Nicolo
    Cacciamani, Giovanni
    Corsi, Paolo
    Inverardi, Davide
    De Marchi, Davide
    Baldassarre, Roberto
    Cerruto, Mariangela
    Ghimenton, Claudio
    Brunelli, Matteo
    Antoniolli, Stefano Zecchini
    Petrozziello, Aldo
    Artibani, Walter
    ARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIA, 2016, 88 (01) : 17 - +
  • [4] The Value of PSA, Free-to-total PSA Ratio and PSA Density in the Prediction of Pathologic Stage for Clinically Localized Prostate Cancer
    Güven Aslan
    Bora İrer
    Aykut Kefi
    İlhan Çelebi
    Kutsal Yörükoğlu
    Adil Esen
    International Urology and Nephrology, 2005, 37 : 511 - 514
  • [5] The value of PSA, free-to-total PSA ratio and PSA density in the prediction of pathologic stage for clinically localized prostate cancer
    Aslan, Guven
    Irer, Bora
    Kefi, Aykut
    Celebi, Ilhan
    Yorukoglu, Kutsal
    Esen, Adil
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2005, 37 (03) : 511 - 514
  • [6] Finding of no tumor (pTO) in patients undergoing radical retropubic prostatectomy for clinically localized prostate cancer
    Mazzucchelli, Roberta
    Barbisan, Francesca
    Galosi, Andrea B.
    ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY, 2007, 29 (05): : 339 - 340
  • [7] Total PSA, free PSA/total PSA ratio, and molecular PSA detection in prostate cancer: Which is clinically effective and when?
    Basso, D
    Fogar, P
    Piva, MG
    Navaglia, F
    Mazza, S
    Prayer-Galetti, T
    Castellucci, E
    Pagano, F
    Plebani, M
    UROLOGY, 2000, 55 (05) : 710 - 715
  • [8] Place of the free PSA/total PSA ratio in staging of localized prostate cancer, based on a series of 50 radical prostatectomies.
    Anfossi, E
    Rossi, D
    Grisoni, V
    Sauvan, R
    Bladou, F
    Serment, G
    PROGRES EN UROLOGIE, 1999, 9 (03): : 479 - 482
  • [9] Brachytherapy versus radical prostatectomy in patients with clinically localized prostate cancer.
    Sharkey J.
    Cantor A.
    Solc Z.
    Huff W.
    Chovnick S.D.
    Behar R.J.
    Perez R.
    Otheguy J.
    Rabinowitz R.
    Current Urology Reports, 2002, 3 (3) : 250 - 257
  • [10] GLOBAL HISTONE MODIFICATIONS PREDICT BIOCHEMICAL RECURRENCE IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY FOR CLINICALLY LOCALIZED PROSTATE CANCER
    Ellinger, J.
    Von Der Gathen, J.
    Kahl, P.
    Guetgemann, I.
    Mueller, S. C.
    Von Ruecker, A.
    Bastian, P. J.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 345 - 345